Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 79106742 | 7910674 | 2 | F | 0 | 20110331 | 20120426 | EXP | 2011GW000196 | MEDICIS | 78.00 | YR | M | N | 0.00000 | 20120307 | MD | NZ |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 79106742 | 7910674 | 1 | PS | IMIQUIMOD | 1 | TOPICAL | 5 PCT;QOD;TOP | D | D | 20723 | |||||||||
| 79106742 | 7910674 | 2 | SS | RITUXIMAB | 1 | 0 | |||||||||||||
| 79106742 | 7910674 | 3 | SS | FLUDARABINE | 1 | 0 | |||||||||||||
| 79106742 | 7910674 | 4 | SS | MITOXANTRONE HYDROCHLORIDE | 1 | 0 | |||||||||||||
| 79106742 | 7910674 | 5 | SS | ACYCLOVIR | 1 | ORAL | 400 MG;TID;PO ; 400 MG;PO | 0 | |||||||||||
| 79106742 | 7910674 | 6 | SS | ACYCLOVIR | 1 | INTRAVENOUS | 750 MG;IV | 0 | |||||||||||
| 79106742 | 7910674 | 7 | SS | CEFTRIAXONE | 1 | INTRAVENOUS | 2 GM;QD;IV | 0 | |||||||||||
| 79106742 | 7910674 | 8 | SS | METRONIDAZOLE | 1 | ORAL | 400 MG;TID;PO ; 400 MG;TID;PO | 0 | |||||||||||
| 79106742 | 7910674 | 9 | SS | BACTRIM | 1 | ORAL | 960 MG;TID;PO | 0 | |||||||||||
| 79106742 | 7910674 | 10 | SS | FOSCARNET SODIUM | 1 | INTRAVENOUS | 2.8 GM;TID;IV | 0 | |||||||||||
| 79106742 | 7910674 | 11 | SS | VALACYCLOVIR | 1 | 500 MG;BID | 0 | ||||||||||||
| 79106742 | 7910674 | 12 | SS | CYCLOPHOSPHAMIDE | 1 | 0 | |||||||||||||
| 79106742 | 7910674 | 13 | SS | VINCRISTINE SULFATE | 1 | 0 | |||||||||||||
| 79106742 | 7910674 | 14 | SS | PREDNISOLONE | 1 | 0 | |||||||||||||
| 79106742 | 7910674 | 15 | SS | CHLORAMBUCIL | 1 | 0 | |||||||||||||
| 79106742 | 7910674 | 16 | SS | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | ORAL | 625 MG TID PO | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 79106742 | 7910674 | 1 | GENITAL HERPES |
| 79106742 | 7910674 | 2 | B-CELL UNCLASSIFIABLE LYMPHOMA LOW GRADE |
| 79106742 | 7910674 | 3 | B-CELL UNCLASSIFIABLE LYMPHOMA LOW GRADE |
| 79106742 | 7910674 | 4 | B-CELL UNCLASSIFIABLE LYMPHOMA LOW GRADE |
| 79106742 | 7910674 | 5 | GENITAL HERPES |
| 79106742 | 7910674 | 6 | GENITAL HERPES |
| 79106742 | 7910674 | 7 | GENITAL HERPES |
| 79106742 | 7910674 | 8 | GENITAL HERPES |
| 79106742 | 7910674 | 9 | GENITAL HERPES |
| 79106742 | 7910674 | 10 | GENITAL HERPES |
| 79106742 | 7910674 | 11 | GENITAL HERPES |
| 79106742 | 7910674 | 12 | B-CELL UNCLASSIFIABLE LYMPHOMA LOW GRADE |
| 79106742 | 7910674 | 13 | B-CELL UNCLASSIFIABLE LYMPHOMA LOW GRADE |
| 79106742 | 7910674 | 14 | B-CELL UNCLASSIFIABLE LYMPHOMA LOW GRADE |
| 79106742 | 7910674 | 15 | B-CELL UNCLASSIFIABLE LYMPHOMA LOW GRADE |
| 79106742 | 7910674 | 16 | GENITAL HERPES |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 79106742 | 7910674 | DE |
| 79106742 | 7910674 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 79106742 | 7910674 | Anal ulcer | |
| 79106742 | 7910674 | Bacteroides test positive | |
| 79106742 | 7910674 | Diffuse large B-cell lymphoma | |
| 79106742 | 7910674 | Disease recurrence | |
| 79106742 | 7910674 | Herpes simplex | |
| 79106742 | 7910674 | Staphylococcus test positive |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 79106742 | 7910674 | HP |
| 79106742 | 7910674 | LIT |
| 79106742 | 7910674 | FGN |
Therapies reported
| no results found |